Literature DB >> 26219253

Medical Costs of Persons with Drug Use Disorders Among Medicaid Managed Care Beneficiaries in Puerto Rico : Comparison of the Direct Services Costs Incurred by Beneficiaries With and Without a Drug Use Disorder.

Héctor M Colón Jordán1, José E Laborde Rivera2, Heriberto A Marín Centeno3, Carmen E Albizu-García1.   

Abstract

Drug use disorders (DUDs) can substantially increase the costs of health care, especially when left untreated. Yet, not much is known about the specific types of medical services that give rise to these cost differences. This study aimed to estimate the medical costs of beneficiaries with DUDs enrolled in the Medicaid Managed Care (MMC) program in Puerto Rico using claims data. These were compared to those of a matched group of patients without DUDs. On average, each beneficiary with a DUD incurred in $4539 annually on medical services compared to $2601 in the matched comparison group, a cost differential of $1938. Close to half of these additional medical costs (43.4%) were generated in the physical health services sector. Counts of service claims were also higher for beneficiaries with DUDs than for beneficiaries without DUDs in all service types, except in outpatient and laboratory services for physical health. A host of access strategies and treatment modalities should be tested to assess the extent to which providing adequate access and adequate treatment for a DUD can contribute to cost savings.

Entities:  

Mesh:

Year:  2016        PMID: 26219253     DOI: 10.1007/s11414-015-9469-4

Source DB:  PubMed          Journal:  J Behav Health Serv Res        ISSN: 1094-3412            Impact factor:   1.505


  15 in total

1.  Economic cost of alcohol and drug abuse in the United States, 1992: a report.

Authors:  H J Harwood; D Fountain; G Fountain
Journal:  Addiction       Date:  1999-05       Impact factor: 6.526

2.  The impact of managed care on substance abuse treatment services.

Authors:  Todd Olmstead; William D White; Jody Sindelar
Journal:  Health Serv Res       Date:  2004-04       Impact factor: 3.402

3.  Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?

Authors:  Susan L Ettner; David Huang; Elizabeth Evans; Danielle Rose Ash; Mary Hardy; Mickel Jourabchi; Yih-Ing Hser
Journal:  Health Serv Res       Date:  2006-02       Impact factor: 3.402

Review 4.  Economic costs of drug abuse: financial, cost of illness, and services.

Authors:  William S Cartwright
Journal:  J Subst Abuse Treat       Date:  2007-06-27

5.  Mental health service use by patients with dysthymic disorder: treatment use and dropout in a 7 1/2-year naturalistic follow-up study.

Authors:  Brian R McFarland; Daniel N Klein
Journal:  Compr Psychiatry       Date:  2005 Jul-Aug       Impact factor: 3.735

Review 6.  Global use of alcohol, drugs and tobacco.

Authors:  Peter Anderson
Journal:  Drug Alcohol Rev       Date:  2006-11

7.  Persons with dual diagnoses of substance abuse and major mental illness: their excess costs of psychiatric care.

Authors:  B Dickey; H Azeni
Journal:  Am J Public Health       Date:  1996-07       Impact factor: 9.308

8.  Costs of addressing heroin addiction in Malaysia and 32 comparable countries worldwide.

Authors:  Jennifer Prah Ruger; Marek Chawarski; Mahmud Mazlan; Craig Luekens; Nora Ng; Richard Schottenfeld
Journal:  Health Serv Res       Date:  2011-10-18       Impact factor: 3.402

9.  Impact of substance disorders on medical expenditures for medicaid beneficiaries with behavioral health disorders.

Authors:  Robin E Clark; Mihail Samnaliev; Mark P McGovern
Journal:  Psychiatr Serv       Date:  2009-01       Impact factor: 3.084

10.  The effect of integrated medical-substance abuse treatment during an acute illness on subsequent health services utilization.

Authors:  Thomas P O'Toole; Robin A Pollini; Daniel E Ford; George Bigelow
Journal:  Med Care       Date:  2007-11       Impact factor: 2.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.